Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from PharmX Technologies ( (AU:PHX) ) is now available.
Pharmx Technologies has appointed Sigma Healthcare Chief Strategy Officer Mark Conway as a non-executive director, effective 13 March 2026, as part of its deepening ties with the wholesale and retail pharmacy sector in Australia and New Zealand. Conway, a former Sigma CFO with extensive experience spanning Fonterra, Fosters Group, Downer EDI Group, and Rio Tinto, is expected to bolster Pharmx’s governance, financial oversight, and strategic execution as it scales its digital platform that connects pharmacies and suppliers.
The appointment follows the recently signed Strategic Alliance Agreement with Sigma Healthcare, underscoring Sigma’s influence on Pharmx’s board and signaling closer operational and strategic collaboration between the two companies. Pharmx’s leadership highlighted Conway’s financial and strategic credentials as critical to advancing its growth agenda, enhancing its infrastructure services, and reinforcing its role as a key digital conduit for pharmacy ordering, eInvoicing, and analytics across the ANZ market.
More about PharmX Technologies
Pharmx Technologies is ANZ’s leading pharmacy ordering platform, providing essential digital infrastructure for ordering and inventory management across Australia and New Zealand. The company connects a large network of pharmacies, suppliers, and technology vendors, processing about $20 billion in transactions annually through its high-availability platform and data-driven solutions in ordering, eInvoicing, and analytics.
Operating in a dynamic healthcare and pharma-tech market, Pharmx targets sustained growth supported by population and demographic trends, as well as regulatory change. By leveraging its proprietary technology and extensive network, the company aims to expand its addressable market, unlock new revenue streams, and improve healthcare outcomes across the region through enhanced connectivity and operational efficiency.
Average Trading Volume: 867,521
Technical Sentiment Signal: Buy
Current Market Cap: A$69.24M
For an in-depth examination of PHX stock, go to TipRanks’ Overview page.